Search research articles
Contact Us
Filters
Showing results (11-20 of 332) with videos related to
Page
of 34
Sort By:
Science (New York, N.Y.)
|
February 16, 2002
Genetics. Please don't call it cloning!
Bert Vogelstein, Bruce Alberts, Kenneth Shine
Proceedings of the National Academy of Sciences of the United States of America
|
January 25, 2013
Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation
Cristian Tomasetti, Bert Vogelstein, Giovanni Parmigiani
Clinical Chemistry
|
January 1, 2015
An interview with Bert Vogelstein and Kenneth Kinzler
Bert Vogelstein, Kenneth Kinzler, Misia Landau
JAMA Oncology
|
April 3, 2020
Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer-Reply
Jeanne Tie, Bert Vogelstein, Peter Gibbs
Nature Protocols
|
November 17, 2007
Genetic knockouts and knockins in human somatic cells
Carlo Rago, Bert Vogelstein, Fred Bunz
Science (New York, N.Y.)
|
March 25, 2017
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Cristian Tomasetti, Lu Li, Bert Vogelstein
Nature Biotechnology
|
August 11, 2006
The role of companion diagnostics in the development and use of mutation-targeted cancer therapies
Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein
Cancer Research
|
September 23, 2003
Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells
Zhenghe Wang, Bert Vogelstein, Kenneth W Kinzler
Genes, Chromosomes & Cancer
|
October 21, 2003
Knudson's hypothesis and the TP53 revolution
Suzanne J Baker, Kenneth W Kinzler, Bert Vogelstein
The Journal of Biological Chemistry
|
March 26, 2003
The Chk2 tumor suppressor is not required for p53 responses in human cancer cells
Prasad V Jallepalli, Christoph Lengauer, Bert Vogelstein, et al.
Page
of 34
Search research articles
Search
Showing results (11-20 of 332) with videos related to
Sort By:
Page
of 34
Science (New York, N.Y.)
|
February 16, 2002
Genetics. Please don't call it cloning!
Bert Vogelstein, Bruce Alberts, Kenneth Shine
Proceedings of the National Academy of Sciences of the United States of America
|
January 25, 2013
Half or more of the somatic mutations in cancers of self-renewing tissues originate prior to tumor initiation
Cristian Tomasetti, Bert Vogelstein, Giovanni Parmigiani
Clinical Chemistry
|
January 1, 2015
An interview with Bert Vogelstein and Kenneth Kinzler
Bert Vogelstein, Kenneth Kinzler, Misia Landau
JAMA Oncology
|
April 3, 2020
Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer-Reply
Jeanne Tie, Bert Vogelstein, Peter Gibbs
Nature Protocols
|
November 17, 2007
Genetic knockouts and knockins in human somatic cells
Carlo Rago, Bert Vogelstein, Fred Bunz
Science (New York, N.Y.)
|
March 25, 2017
Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention
Cristian Tomasetti, Lu Li, Bert Vogelstein
Nature Biotechnology
|
August 11, 2006
The role of companion diagnostics in the development and use of mutation-targeted cancer therapies
Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein
Cancer Research
|
September 23, 2003
Phosphorylation of beta-catenin at S33, S37, or T41 can occur in the absence of phosphorylation at T45 in colon cancer cells
Zhenghe Wang, Bert Vogelstein, Kenneth W Kinzler
Genes, Chromosomes & Cancer
|
October 21, 2003
Knudson's hypothesis and the TP53 revolution
Suzanne J Baker, Kenneth W Kinzler, Bert Vogelstein
The Journal of Biological Chemistry
|
March 26, 2003
The Chk2 tumor suppressor is not required for p53 responses in human cancer cells
Prasad V Jallepalli, Christoph Lengauer, Bert Vogelstein, et al.
Page
of 34